Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gliclazide versus linagliptin for hypoglycaemia in type 2 diabetes with chronic kidney disease
ISRCTN17462005Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Continue gliclazide with Switch to linagliptin (2 arms). Primary endpoints: Overall glycaemic control and Percent of time spent in hypoglycaemia. Started Jun 2016; status: completed.
02
Drugs
gliclazidelinagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN17462005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17462005.